Personalized medicine in sports cardiology: managing the known unknowns-Reference-Cited by-同舟云学术

Personalized medicine in sports cardiology: managing the known unknowns

Published:2023-05-17 Issue:9 Volume:30 Page:868-870
ISSN:2047-4873
Container-title:European Journal of Preventive Cardiology
language:en
Short-container-title:

Author:

Monda Emanuele¹²,Elliott Perry Mark²^ORCID

Affiliation:

1. Inherited and Rare Cardiovascular Diseases, Department of Translational Medical Sciences, University of Campania ‘Luigi Vanvitelli’ , Naples , Italy

2. Institute of Cardiovascular Science, University College of London and St. Bartholomew's Hospital , 5 University St., London WC1E 6JF , UK

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Epidemiology

Link

https://academic.oup.com/eurjpc/advance-article-pdf/doi/10.1093/eurjpc/zwad153/50411430/zwad153.pdf

Reference15 articles.

1. Aetiology and incidence of sudden cardiac arrest and death in young competitive athletes in the USA: a 4-year prospective study;Peterson;Br J Sports Med,2021

2. Physical activity in hypertrophic cardiomyopathy: prevalence of inactivity and perceived barriers;Sweeting;Open Heart,2016

3. Impact of demographic features, lifestyle, and comorbidities on the clinical expression of hypertrophic cardiomyopathy;Finocchiaro;JAHA,2017

4. Recommendations for participation in competitive and leisure time sport in athletes with cardiomyopathies, myocarditis, and pericarditis: position statement of the sport cardiology section of the European Association of Preventive Cardiology (EAPC);Pelliccia;Eur Heart J,2019

5. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: task force 3: hypertrophic cardiomyopathy, arrhythmogenic right ventricular cardiomyopathy and other cardiomyopathies, and myocarditis: a scientific statement from the American heart association and American college of cardiology;Maron;Circulation,2015